DNA methylation-mediated silencing of ANGPTL4 induces the activation of cancer-associated fibroblasts (CAFs) and help CRC transfer through the ERK pathway, enhancing its invasive ability [81]. This evidence concerns the gene ANGPTL4 and cancer.